Jan 07, 2021
MilliporeSigma Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics
Dec 07, 2020
MilliporeSigma Expands Production Capacities
Nov 20, 2020
Massachusetts-based Businesses of Merck KGaA, Darmstadt, Germany Named to The Boston Globe's 'Top Places to Work' List
Oct 08, 2020
MilliporeSigma Celebrates Topping-Out Ceremony for New Membrane Production Plant
Oct 06, 2020
MilliporeSigma Inaugurates New, Upgraded Onsite Industrial Water Treatment Plant
Sep 09, 2020
MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion
Jul 10, 2020
MilliporeSigma Opens its Largest M Lab(TM) Collaboration Center in Shanghai
May 27, 2020
MilliporeSigma and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19
May 11, 2020
MilliporeSigma Granted U.S. Patents for Foundational CRISPR-Cas9 Technology
Mar 03, 2020
MilliporeSigma's New LANEXO(TM) System to Improve Scientists' Productivity in the Lab
Dec 19, 2019
MilliporeSigma Licenses Foundational CRISPR Integration Technology to Promega
Nov 26, 2019
Japan and Singapore Grant CRISPR Patents to MilliporeSigma
Nov 12, 2019
MilliporeSigma Licenses CRISPR Gene-Editing Technology to Evotec
Aug 19, 2019
MilliporeSigma Granted 20 CRISPR Patents Total Worldwide
Jun 20, 2019
Massachusetts-based Business Sectors of Merck KGaA, Darmstadt, Germany Named 'Best Places to Work' by Boston Business Journal
May 20, 2019
MilliporeSigma Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing
Mar 20, 2019
MilliporeSigma Opens First M Lab(TM) Collaboration Center in Europe
Mar 19, 2019
MilliporeSigma to Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China
Mar 04, 2019
MilliporeSigma Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology
Feb 19, 2019
MilliporeSigma Receives First U.S. Patent for Improved CRISPR Genome-Editing Method